| Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More | Sarah de Crescenzo | 12/06/19 | National |
| IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator | Frank Vinluan | 12/02/19 | Boston |
| New Faces, Big Impact: Meet the Finalists For Xconomy’s Newcomer Award | Ben Fidler | 08/07/18 | Boston |
| The 2018 Xconomy Awards Finalists Are… | Corie Lok | 06/28/18 | Boston |
| The Revolution in Inflammation Drug Development | Gary Glick | 05/15/18 | Boston |
| Last Chance to Save on Boston’s Life Science Disruptors | Jamie Gulden | 09/20/17 | Boston |
| IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout | Ben Fidler | 08/03/17 | Boston |
| Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases | Ben Fidler | 06/22/16 | Boston |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout | Sarah Schmid Stevenson | 06/11/15 | Detroit Ann Arbor |
| Lycera Enters Into Second Collaboration Deal with Merck | Sarah Schmid Stevenson | 02/12/13 | Detroit Ann Arbor |
| Who Needs a CEO? Lycera Strikes Deal with Pharma Giant Merck | Thomas Lee | 03/03/11 | Detroit Ann Arbor |
| Lycera Plows Ahead With Drugs To Treat Autoimmune Disorders | Thomas Lee | 02/24/11 | Detroit Ann Arbor |
| Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence | Luke Timmerman | 09/17/10 | Detroit Ann Arbor |
| Rising from the Ashes of Pfizer: The Michigan Contract Research Organization Cluster | Luke Timmerman | 07/01/10 | Detroit Ann Arbor |
| It Seems Everybody Has Advice For Michigan; What Do You Think? | Howard Lovy | 05/06/10 | Detroit Ann Arbor |
| Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs | Luke Timmerman | 04/28/10 | Detroit Ann Arbor |
| Four Key Ingredients Needed to Spark Innovation in Michigan | Gary Glick | 04/26/10 | Detroit Ann Arbor |
| Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO | Luke Timmerman | 01/07/10 | Boston |
